Developer docs
API playgroundTry for free, no card

Search company profiles

Instrument Business Outlook

Full company profile

uuid002qugr

Namestring
Instrument Business Outlook
Legal namestring
Science and Medicine Group
Company typeenum
Private
Founded yearint
1996
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLos Angeles, United States
HQ citystring
Los Angeles
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
industry intelligence services, analytical instrument news, life science market research, subscription newsletters, market data analysis
NAICS code1 code
  • Periodical Publishers513120
SIC code1 code
  • Periodicals: Publishing Or Publishing & Printing2721
Product category
Industry Intelligence Services / B2B Trade Publishing
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Subscription Revenue
TypeSubscription Recurring
Description

IBO generates revenue primarily through annual and multi-year subscription licenses. Subscriptions range from single-user to enterprise-level (unlimited users) with tiered pricing. Discounts are offered for multi-year commitments (10% for 2-year, 15% for 3-year). The publication is delivered online 24 times per year.

instrumentbusinessoutlook.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details6 tiers
1Single user license - 1, 2, or 3 year terms
ModelSubscriptionBilling cadenceAnnual
Notes

$2,500.00 for 1-year; 10% discount for 2-year; 15% discount for 3-year

instrumentbusinessoutlook.com
2Team license - 5 users with 1, 2, or 3 year terms
ModelSubscriptionBilling cadenceAnnual
Notes

Multi-user discount structure; 10% discount for 2-year; 15% discount for 3-year

instrumentbusinessoutlook.com
3Group license - 15 users with 1, 2, or 3 year terms
ModelSubscriptionBilling cadenceAnnual
Notes

Mid-tier team pricing; 10% discount for 2-year; 15% discount for 3-year

instrumentbusinessoutlook.com
4Department license - 50 users with 1, 2, or 3 year terms
ModelSubscriptionBilling cadenceAnnual
Notes

Online-access only tier to prevent unlawful distribution; 10% discount for 2-year; 15% discount for 3-year

instrumentbusinessoutlook.com
5Corporate license - 250 users with 1, 2, or 3 year terms
ModelSubscriptionBilling cadenceAnnual
Notes

Large enterprise tier; 10% discount for 2-year; 15% discount for 3-year

instrumentbusinessoutlook.com
6Enterprise license - Unlimited users with 1, 2, or 3 year terms
ModelSubscriptionBilling cadenceAnnual
Notes

Maximum tier with unlimited user access; 10% discount for 2-year; 15% discount for 3-year

instrumentbusinessoutlook.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Instrument Business Outlook is a twice-monthly digital newsletter subscription (24 issues per year) delivering strategic information, curated industry news, financial results coverage, M&A tracking, and proprietary Strategic Directions International (SDi) data and analysis tailored for executives and investors in the life science and analytical instrument industry. Subscribers receive access to searchable 10+ year archives, exportable charts and figures, an indexed press release library of 300+ companies, plus annual forecast issues and biannual business climate surveys.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Instrument Business Outlook (IBO) is a single unified product—a twice-monthly digital newsletter subscription service for the life science and analytical instrument industry. The core offering is the IBO newsletter, which includes various content components: Feature Articles (covering market dynamics, acquisitions, and trends), Financial Articles (company results and stock performance), Market Profiles (technology overviews with vendor and market data from SDi analysts), Region and Industry Watch content, and an indexed press release library. Subscribers also receive access to Annual Forecast Issues (sales forecasts for 10 technology sectors), Annual Reviews of R&D spending, executive compensation, and M&A activities, plus a Biannual Business Climate Survey—all included as part of the subscription. The publication covers analytical technologies including life sciences instrumentation, mass spectrometry, chromatography, informatics, microscopy, molecular spectrometry, atomic spectrometry, and related consumables. Pricing tiers range from single-user licenses to unlimited enterprise access, with subscriptions ranging from $2,500 to $76,500.

Product and service1 record
1Instrument Business Outlook (IBO) Newsletter Subscription
CategoryIndustry Intelligence Newsletter Subscription
Description

A twice-monthly digital newsletter subscription (24 issues per year) providing strategic information, curated industry news, financial results, M&A coverage, exclusive interviews, and proprietary SDi data and analysis for executives and investors in the life science and analytical instrument industry. Delivered online with access to searchable 10+ year archives, exportable charts and figures, an indexed press release library of 300+ companies, the annual Forecast Issue for 10 technology sectors, annual R&D/executive compensation/M&A reviews, and a biannual business climate survey. Sold via user-based tiered licenses from single-user to unlimited enterprise access.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Science and Medicine Group is the parent company and publisher of Instrument Business Outlook. The organization also owns related brands including AuntMinnie.com, DrBicuspid.com, SDi (Strategic Directions International), and the Science Advisory Board. IBO is described as a publication of Science and Medicine Group.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

SDi provides proprietary data and analysis to IBO, including the annual forecast issue with sales forecasts and market breakdowns for 10 technology sectors. SDi is a business intelligence firm specializing in the analytical instrument market and produces reports such as the Global Assessment Report.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Life sciences industry news, career, and intelligence platform covering biopharma, diagnostics, and analytical tools. Comparable to IBO in audience (industry executives and job-seeking scientists) and beat overlap, though broader than IBO's instrument focus.

TypeDirect peer
Description

B2B publication serving lab managers and decision-makers across life science and analytical laboratories, with coverage of new instruments, lab products, and industry trends. Closely comparable to IBO's audience and instrument/product focus.

TypeDirect peer
Description

Daily newsletter and digital publication covering biotech industry news, financings, R&D, and dealmaking. Comparable to IBO in verticalized B2B newsletter format, though IBO is more instrument-focused while Fierce is broader biotech.

TypeDirect peer
Description

Subscription-based biopharma intelligence service delivering daily news, analysis, and proprietary data (e.g., BCIQ) to industry executives and investors. Highly comparable to IBO in paid-newsletter economics, analyst-driven content, and investor-grade audience.

TypeDirect peer
Description

Sister publication within Science and Medicine Group, providing daily news, analysis, and community for the medical imaging industry. Same parent, same business model, similar subscription mechanics — highly comparable as a peer in the same portfolio.

TypeDirect peer
Description

Industry publication covering drug discovery technologies, including analytical instruments such as mass spectrometry, chromatography, and lab automation — directly overlapping IBO's core beat and serving a similar executive/scientist audience.

TypeDirect peer
Description

Subscription-based pharma and biotech newsroom producing daily newsletters and breaking news targeted at biopharma executives, investors, and analysts. Comparable to IBO in paid newsletter format, executive/investor buyer, and life science industry focus.

TypeDirect peer
Description

Flagship news publication of the American Chemical Society covering the chemical, instrumentation, and life science industries. Comparable to IBO in providing curated industry news, financial analysis, and analytical instrument coverage to a professional audience.

TypeDirect peer
Description

Long-running B2B newsletter and digital publication covering the biotechnology and life science tools industries, including analytical instrumentation. Closely comparable to IBO in audience (executives/investors), subscription model, and beat (life science R&D tools).

TypeOthers
Description

Market intelligence firm providing proprietary data, forecasts, and the Global Assessment Report for the analytical instrument industry. SDi is IBO's exclusive data partner and a sister company under Science and Medicine Group, making it a directly adjacent peer in the same niche.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Instrument Business Outlook

Industry Intelligence Services / B2B Trade Publishinginstrumentbusinessoutlook.com

Instrument Business Outlook firmographics

Firmographics
Name
Instrument Business Outlook
Legal name
Science and Medicine Group
Website
https://instrumentbusinessoutlook.com
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Where Instrument Business Outlook is headquartered

Location

Headquarters

HQ city
Los Angeles
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Instrument Business Outlook business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Subscription Revenue: IBO generates revenue primarily through annual and multi-year subscription licenses. Subscriptions range from single-user to enterprise-level (unlimited users) with tiered pricing. Discounts are offered for multi-year commitments (10% for 2-year, 15% for 3-year). The publication is delivered online 24 times per year.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualSingle user license - 1, 2, or 3 year terms
SubscriptionAnnualTeam license - 5 users with 1, 2, or 3 year terms
SubscriptionAnnualGroup license - 15 users with 1, 2, or 3 year terms
SubscriptionAnnualDepartment license - 50 users with 1, 2, or 3 year terms
SubscriptionAnnualCorporate license - 250 users with 1, 2, or 3 year terms
SubscriptionAnnualEnterprise license - Unlimited users with 1, 2, or 3 year terms

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Instrument Business Outlook product offering

Product offering

Core offering

Instrument Business Outlook is a twice-monthly digital newsletter subscription (24 issues per year) delivering strategic information, curated industry news, financial results coverage, M&A tracking, and proprietary Strategic Directions International (SDi) data and analysis tailored for executives and investors in the life science and analytical instrument industry. Subscribers receive access to searchable 10+ year archives, exportable charts and figures, an indexed press release library of 300+ companies, plus annual forecast issues and biannual business climate surveys.

Product overview

Instrument Business Outlook (IBO) is a single unified product—a twice-monthly digital newsletter subscription service for the life science and analytical instrument industry. The core offering is the IBO newsletter, which includes various content components: Feature Articles (covering market dynamics, acquisitions, and trends), Financial Articles (company results and stock performance), Market Profiles (technology overviews with vendor and market data from SDi analysts), Region and Industry Watch content, and an indexed press release library. Subscribers also receive access to Annual Forecast Issues (sales forecasts for 10 technology sectors), Annual Reviews of R&D spending, executive compensation, and M&A activities, plus a Biannual Business Climate Survey—all included as part of the subscription. The publication covers analytical technologies including life sciences instrumentation, mass spectrometry, chromatography, informatics, microscopy, molecular spectrometry, atomic spectrometry, and related consumables. Pricing tiers range from single-user licenses to unlimited enterprise access, with subscriptions ranging from $2,500 to $76,500.

Differentiator

Problem solved

Functional benefit

Products and services

  • Instrument Business Outlook (IBO) Newsletter Subscription A twice-monthly digital newsletter subscription (24 issues per year) providing strategic information, curated industry news, financial results, M&A coverage, exclusive interviews, and proprietary SDi data and analysis for executives and investors in the life science and analytical instrument industry. Delivered online with access to searchable 10+ year archives, exportable charts and figures, an indexed press release library of 300+ companies, the annual Forecast Issue for 10 technology sectors, annual R&D/executive compensation/M&A reviews, and a biannual business climate survey. Sold via user-based tiered licenses from single-user to unlimited enterprise access.

Companies that use Instrument Business Outlook

Customer profile

Segments3 records

Ideal customer profiles3 records

Instrument Business Outlook technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Instrument Business Outlook partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Science and Medicine GroupcoreStrategic or Co-development PartnerScience and Medicine Group is the parent company and publisher of Instrument Business Outlook. The organization also owns related brands including AuntMinnie.com, DrBicuspid.com, SDi (Strategic Directions International), and the Science Advisory Board. IBO is described as a publication of Science and Medicine Group.
  • Strategic Directions International (SDi)coreStrategic or Co-development PartnerSDi provides proprietary data and analysis to IBO, including the annual forecast issue with sales forecasts and market breakdowns for 10 technology sectors. SDi is a business intelligence firm specializing in the analytical instrument market and produces reports such as the Global Assessment Report.

Scale indicators4 records

Recent moves5 records

Expansion highlights3 records

Instrument Business Outlook competitors and assessment

Company assessment

Direct peers

  • BioSpace: Life sciences industry news, career, and intelligence platform covering biopharma, diagnostics, and analytical tools. Comparable to IBO in audience (industry executives and job-seeking scientists) and beat overlap, though broader than IBO's instrument focus.
  • Lab Manager Magazine: B2B publication serving lab managers and decision-makers across life science and analytical laboratories, with coverage of new instruments, lab products, and industry trends. Closely comparable to IBO's audience and instrument/product focus.
  • Fierce Biotech: Daily newsletter and digital publication covering biotech industry news, financings, R&D, and dealmaking. Comparable to IBO in verticalized B2B newsletter format, though IBO is more instrument-focused while Fierce is broader biotech.
  • BioCentury: Subscription-based biopharma intelligence service delivering daily news, analysis, and proprietary data (e.g., BCIQ) to industry executives and investors. Highly comparable to IBO in paid-newsletter economics, analyst-driven content, and investor-grade audience.
  • AuntMinnie.com: Sister publication within Science and Medicine Group, providing daily news, analysis, and community for the medical imaging industry. Same parent, same business model, similar subscription mechanics — highly comparable as a peer in the same portfolio.
  • Drug Discovery & Development: Industry publication covering drug discovery technologies, including analytical instruments such as mass spectrometry, chromatography, and lab automation — directly overlapping IBO's core beat and serving a similar executive/scientist audience.
  • Endpoints News: Subscription-based pharma and biotech newsroom producing daily newsletters and breaking news targeted at biopharma executives, investors, and analysts. Comparable to IBO in paid newsletter format, executive/investor buyer, and life science industry focus.
  • Chemical & Engineering News (C&EN): Flagship news publication of the American Chemical Society covering the chemical, instrumentation, and life science industries. Comparable to IBO in providing curated industry news, financial analysis, and analytical instrument coverage to a professional audience.
  • Genetic Engineering & Biotechnology News (GEN): Long-running B2B newsletter and digital publication covering the biotechnology and life science tools industries, including analytical instrumentation. Closely comparable to IBO in audience (executives/investors), subscription model, and beat (life science R&D tools).

Others

  • Strategic Directions International (SDi): Market intelligence firm providing proprietary data, forecasts, and the Global Assessment Report for the analytical instrument industry. SDi is IBO's exclusive data partner and a sister company under Science and Medicine Group, making it a directly adjacent peer in the same niche.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Instrument Business Outlook social profiles

Digital presence

Instrument Business Outlook financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Instrument Business Outlook leadership team

Management profile

Number of profiles

Profiles2 records

Instrument Business Outlook funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Instrument Business Outlook M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Instrument Business Outlook

What does Instrument Business Outlook do?

Instrument Business Outlook is a twice-monthly digital newsletter subscription (24 issues per year) delivering strategic information, curated industry news, financial results coverage, M&A tracking, and proprietary Strategic Directions International (SDi) data and analysis tailored for executives and investors in the life science and analytical instrument industry. Subscribers receive access to searchable 10+ year archives, exportable charts and figures, an indexed press release library of 300+ companies, plus annual forecast issues and biannual business climate surveys.

Is Instrument Business Outlook a public or private company?

Instrument Business Outlook is a private company. It is classified as corporate owned and is currently operating.

When was Instrument Business Outlook founded?

Instrument Business Outlook was founded in 1996. It employs 1 to 10 people.

Where is Instrument Business Outlook based?

Instrument Business Outlook is headquartered in Los Angeles, United States, in the North America region.

How does Instrument Business Outlook make money?

One revenue line is on record: subscription Revenue.

Who are Instrument Business Outlook's main competitors?

Direct peers on record are BioSpace, Lab Manager Magazine, Fierce Biotech, BioCentury, AuntMinnie.com, Drug Discovery & Development, Endpoints News, Chemical & Engineering News (C&EN) and Genetic Engineering & Biotechnology News (GEN). Strategic Directions International (SDi) is listed as an others.

Does Instrument Business Outlook have an API?

No public API is recorded for Instrument Business Outlook.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals